Mereo BioPharma (AgeTech UK) Biomed
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Headquarters:
United Kingdom
Founded Date:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
AgeTech Companies
Employee Number:
N/A
Industry:
UK AgeTech 2020
Funding Status:
N/A